124 filings
Page 3 of 7
8-K
8qloxid
29 Apr 21
Departure of Directors or Certain Officers
4:31pm
8-K
bhg4z1r1 la7r
1 Apr 21
Departure of Directors or Certain Officers
8:42am
8-K
jfr3nht9 6qhh
5 Mar 21
Departure of Directors or Certain Officers
12:00am
8-K
fwh063y
25 Feb 21
Lantheus Reports Fourth Quarter and Full Year 2020 Financial Results
4:08pm
8-K
ftgxcck7clm7
1 Feb 21
Other Events
7:00am
8-K
5lat9suz2u0
9 Dec 20
Lantheus Holdings Announces Acceptance and Priority Review of New Drug Application for PyLTM (18F-DCFPyL), a PSMA-Targeted Prostate Cancer PET Imaging Agent
3:28pm
8-K
6uzq coyvr34
3 Dec 20
Transaction Extends Relationship with Strategic Partner
7:06am
8-K
uk4u9iu4yd3 e8z5f2l
18 Nov 20
Lantheus Holdings, Inc. Announces FDA Approval of DEFINITY® Room Temperature
4:19pm
8-K
dqr4xu4z1b4ww7q9ke8z
5 Nov 20
Lantheus Holdings, Inc. Reports Third Quarter 2020 Financial Results
7:45am
8-K
80c5mjs
5 Oct 20
Other Events
4:30pm
8-K
m4lv8h
30 Sep 20
Other Events
8:15am
8-K
37x8dyu7jqtd3
30 Jul 20
Lantheus Holdings, Inc. Reports Second Quarter 2020 Financial Results
8:33am
8-K
yobmw0
22 Jun 20
Entry into a Material Definitive Agreement
7:15am
8-K
2tt6ut
22 Jun 20
Lantheus Completes Merger with Progenics
7:12am
8-K
6omei7avo1nt73epxi5
16 Jun 20
Lantheus Stockholders Approve Share Issuance For Merger with Progenics
4:11pm
8-K
n6yvfua
30 Apr 20
Lantheus Holdings, Inc. Reports First Quarter 2020 Financial Results
7:49am
8-K
rwkat d4f9
24 Apr 20
Submission of Matters to a Vote of Security Holders
4:31pm
8-K
y74 mrlhrihnxjk5g6
14 Apr 20
Velan Capital Agrees to Support Merger of Lantheus and Progenics
9:02am
8-K
o459 nwfigk57dwa
10 Apr 20
Departure of Directors or Certain Officers
8:30am
8-K
3girwumzu3oscn
9 Apr 20
Results of Operations and Financial Condition
8:30am